Ascendis Pharma (spons. ADRs) Aktie
138,00
EUR
+1,00
EUR
+0,73
%
152,67
USD
+0,08
USD
+0,05
%
Werbung
Ascendis Pharma (spons. ADRs) Aktie Analyse
24.01.19 | Ascendis Pharma (spons. ADRs) Overweight | Cantor Fitzgerald | |
26.06.18 | Ascendis Pharma (spons. ADRs) Buy | Stifel, Nicolaus & Co., Inc. | |
26.09.16 | Ascendis Pharma (spons. ADRs) Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung